Abstract: Mitochondrial compositions and therapeutic methods of using same. Compositions of partially purified functional mitochondria and methods of using the compositions to treat conditions which benefit from increased mitochondrial function by administering the compositions to a subject in need thereof.
Abstract: The present invention relates to a pharmaceutical composition for treating cerebrovascular diseases including stem cell-derived exosomes as an active ingredient. The stem cell-derived exosomes according to the present invention have superior nerve cell protective effects, such as inhibition of cerebral ventricular distention, reduction of hydrocephalus, and inhibition of nerve cell death and cellular inflammation in an intraventricular hemorrhage (IVH) animal model, and thus, can be useful in treating cerebrovascular diseases including intraventricular hemorrhage, etc.
Type:
Grant
Filed:
December 12, 2014
Date of Patent:
January 1, 2019
Assignee:
Samsung Life Public Welfare Foundation
Inventors:
Yun Sil Chang, Won Soon Park, Dong Kyung Sung, So Yoon Ahn
Abstract: The present invention provides a method for preparing an artificial heart valve leaflet, comprising freezing an animal tissue membrane and processing the frozen animal tissue membrane so as to reach a preset thickness. The method, by processing the frozen animal tissue membrane, can conveniently obtain an artificial heart valve leaflet with a required thickness and increase the yield of the animal tissue membrane valve leaflet.
Type:
Grant
Filed:
June 29, 2016
Date of Patent:
December 11, 2018
Assignee:
KINGSTRONBIO (CHANGSHU) CO., LTD.
Inventors:
Shengping Sam Zhong, Chang Jin, Jing Liu
Abstract: A scaffold comprising an aligned fiber. The invention further relates to a scaffold comprising one or more electrospun fibers wherein a fast Fourier transform (FFT) analysis result of the fibers have adjacent major peaks with about 180? apart from each other. Methods for promoting differentiation of stem cells into osteoblasts, chondrocytes, ligament or tendon, the method comprising culturing the cells on the scaffold or aligned fiber in conditions suitable for the cell differentiation.
Abstract: The invention relates to a synthetic bone material and a process for making the same. The synthetic bone material may comprise multiple phases of calcium phosphate. Another aspect of the invention is a porous filter, and the method of making the same, and wherein the porous filter is substantially similar to the process for forming the synthetic bone material.
Abstract: Implants having improved mechanical properties and/or degradation profiles, kits including such implants, and methods of producing and using the same.
Abstract: The invention is in the field of therapeutic treatment of tumors. The inventors have found that microvesicles derived from adult stem cells exert a remarkable anti-tumor effect when administered to a patient affected by a tumor disease. Preferred microvesicles are derived from a bone marrow-mesenchymal stem cell, a glomerular mesenchymal stem cell or a non-oval liver stem cell.
Type:
Grant
Filed:
June 12, 2017
Date of Patent:
October 23, 2018
Assignee:
FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH
Inventors:
Stefania Bruno, Maria Beatriz Herrera Sanchez, Valentina Fonsato, Giovanni Camussi, Ciro Tetta
Abstract: The present invention relates to a process for the separation of a mixture of a protein and its reaction product with a polyalkylene glycol, comprising the steps: a) providing a mixture comprising the protein and the reaction product in a fluid, b) bringing the mixture of step a) into contact with a microporous cellulose acetate membrane with adsorption of the reaction product onto the cellulose acetate membrane, the protein not becoming adsorbed onto the cellulose acetate membrane, c) removal of the protein from the cellulose acetate membrane, and d) desorbing the reaction product from the cellulose acetate membrane, the reaction product being selected from the group comprising the protein which is mono- or polyfunctionalized by the polyalkylene glycol, or mixtures thereof.
Type:
Grant
Filed:
March 21, 2012
Date of Patent:
October 16, 2018
Assignee:
SARTORIUS STEDIM BIOTECH GMBH
Inventors:
Wolfgang Demmer, Louis Villain, Hans-Heinrich Hoerl
Abstract: A composition that includes spray-dried yoghurt powder and at least one anionic surfactant and/or at least one fatty acid soap, may be used as a prebiotic for inhibiting the growth and/or the physiological activity of undesired skin bacteria and/or for obtaining desired skin bacteria. A prebiotically effective cosmetic composition includes: a) at least one fatty acid soap in a weight proportion of between 20 and 75 wt. %, preferably between 30 and 70 wt. %, particularly preferably between 40 and 65 wt. %, and in particular between 45 and 60 wt. %; and b) spray-dried yoghurt powder in a weight proportion of between 0.01 and 10 wt. %, preferably 0.02 and 7.5 wt. %, particularly preferably between 0.03 and 5 wt. %, and in particular between 0.05 and 3 wt. %, wherein the amounts relate to the total weight of the cosmetic composition.
Abstract: The present disclosure concerns plant extracts which have been fermented with kefir grains, methods of production of these extracts, a powder comprising these extracts and compositions comprising these extracts. Since these extracts have a high content of aglycone active principles, their biological activities are high and their applications are varied.
Type:
Grant
Filed:
April 20, 2015
Date of Patent:
October 2, 2018
Assignee:
KEFIPLANT INC.
Inventors:
Chantale Houle, Serge Rollan, Christian Deshayes
Abstract: Methods and systems for obtaining platelets are disclosed. Platelets are collected in a pre-determined volume of plasma and a determined amount of a combined storage medium including the pre-determined amount of plasma and a volume of a synthetic additive solution.
Abstract: The present invention relates to fermentation processes. The objective of the invention was to provide methods for producing nisin containing ferments and formulating such ferments into preservatives. It was in particular an object of the present invention to provide improved processes for producing nisin containing ferments by simple and efficient (batch) culturing and allowing for simple down-stream processing either into a liquid, semi-liquid or a dry powder product, having sufficient nisin content and stability, good handling properties and satisfactory organoleptic properties. Such processes are provided, as well as the products that can be obtained with it and their use.
Type:
Grant
Filed:
January 15, 2014
Date of Patent:
August 7, 2018
Assignee:
PURAC BIOCHEM B.V.
Inventors:
Arne Olav Sliekers, Jasper Meijer, Diana Visser
Abstract: The present invention discloses a novel method for biological reduction of the carboxylic acids to their corresponding aldehydes and/or alcohols with high productivity and high yield by using fungus in the category of basidiomycetes. This reduction is specific and selective for its functional group (—COOH), without affecting other functional group such as—R groups (—OH, —NH2, -alkyl, -alkyoxy) and their position, number on aromatic ring. The method of the invention relates to reduction of aryl acids to aldehyde and/or alcohols by employing a white rot fungus—Pycnoporus cinnabarinus, an organism of basidiomycete species, grown in vessel/column. The biotransformation was performed in vessel/column/fermentor with pH control, dissolved oxygen, membrane system, product extractor is attached.
Abstract: The invention is a novel method of sterilizing bone and soft tissues intended for human transplantation. In one embodiment the process includes steps of subjecting transplants to high hydrostatic pressures of aqueous fluid to which chlorhexidine gluconate or similar sterilizing chemicals have been added.
Abstract: Provided are methods for preparing gelled, solubilized extracellular matrix (ECM) compositions useful as cell growth scaffolds. Also provided are compositions prepared according to the methods as well as uses for the compositions. In one embodiment a device, such as a prosthesis, is provided which comprises an inorganic matrix into which the gelled, solubilized ECM is dispersed to facilitate in-growth of cells into the ECM and thus adaptation and/or attachment of the device to a patient.
Type:
Grant
Filed:
February 18, 2014
Date of Patent:
June 26, 2018
Assignee:
University of Pittsburgh—Of the Commonwealth System of Higher Education
Abstract: Provided are a culture medium of an adipose-derived stem cell, a method for preparing the same, and a composition for promoting hair growth, in which the composition includes the culture medium. The adipose-derived stem cell (ADSC-T) according to the present invention exhibits long lifespan, improved cell proliferation rate, and extended proliferation period, as compared with a primary adipose-derived stem cell (ADSC), and thus, the adipose-derived stem cell (ADSC-T) can be usefully used for the study about the adipose-derived stem cell and the mass production of the culture medium of the adipose-derived stem cell. In addition, according to the present invention, the culture medium of the adipose-derived stem cell (ADSC-T) that expresses a T antigen of SV40 exhibits excellent hair growth effectiveness and can be usefully used as a raw material for the hair loss prevention and hair growing agents.
Type:
Grant
Filed:
August 29, 2012
Date of Patent:
June 19, 2018
Assignee:
CHANGWON NATIONAL UNIVERSITY INDUSTRY ACADEMY COOP
Inventors:
Dong Wan Kim, Mi Jung Seo, Gwang Lee, Woo Hong Joo, Sun Hee Kim
Abstract: Methods of generating an innervated muscle structures are disclosed as well as bioengineered structures for tissue repair or regeneration. The methods can include the steps of obtaining populations of smooth muscle cells and neuronal progenitor cells and then seeding the cells together onto a matrix material, followed by culturing the seeded cells to form an innervated smooth muscle cell construct of directionally oriented smooth muscle cells. In one embodiment, the neuronal progenitor cells can be seeded first as neurospheres in a biocompatible solution, e.g., a collagen/laminin solution, and allowed to gel. Next, a second suspension of smooth muscle cells can be deposited as separate layer. Multiple layer structures of alternating muscle or neuron composition can also be formed in this manner. Differentiation of the neuronal progenitor cells can be induced by exposure to a differentiation medium, such as Neurobasal A medium and/or exposure to a differentiating agent, such as B-27 supplement.
Abstract: The present invention relates to apparatus, methods, and applications for treating wastewater collection systems contaminated with fats, oils and grease (FOG), such as wet wells, transfer or lift stations, or main sewer lines, and more particularly to biological processes for removing the FOG from wastewater. This invention further relates to apparatus and methods for growing microbes on-site at a wastewater treatment facility or FOG-contaminated wastewater collection system location, and for economically inoculating sufficient microbes to solve various treatment problems rapidly.
Abstract: Methods for treating tissue matrices and tissue matrices produced according to the methods are provided. The methods can include treating a tissue matrix with a proteolytic enzyme to produce a desired pliability of the tissue matrix and/or to control the immunogenicity of the tissue matrix. The methods can also comprise performing an assay to determine if contacting the at least one collagen-containing tissue matrix with a proteolytic enzyme has altered the at least one collagen-containing tissue matrix to reduce a human immune response to the tissue matrix.
Type:
Grant
Filed:
December 8, 2015
Date of Patent:
May 1, 2018
Assignee:
LifeCell Corporation
Inventors:
Yi Chen, Hui Xu, Li Ting Huang, Wenquan Sun, Hua Wan